| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 73.802 | 63.703 | 66.312 | 86.458 | 81.756 | 99.338 | 99.873 | 97.355 | 81.915 | 73.860 |
| Total Income - EUR | 74.178 | 92.057 | 66.674 | 86.497 | 81.802 | 99.352 | 99.885 | 97.400 | 81.980 | 90.302 |
| Total Expenses - EUR | 73.858 | 77.383 | 44.223 | 95.237 | 80.548 | 110.376 | 74.766 | 116.407 | 78.391 | 81.990 |
| Gross Profit/Loss - EUR | 320 | 14.674 | 22.451 | -8.739 | 1.254 | -11.025 | 25.119 | -19.007 | 3.588 | 8.313 |
| Net Profit/Loss - EUR | 60 | 13.434 | 21.785 | -9.605 | 605 | -11.947 | 24.120 | -19.837 | 2.785 | 6.816 |
| Employees | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Profarm Farmacia Elixir Boldesti S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 9.754 | 9.137 | 8.474 | 7.819 | 7.179 | 7.113 | 6.416 | 5.895 | 5.338 | 5.597 |
| Current Assets | 51.484 | 26.413 | 49.875 | 47.384 | 48.303 | 39.893 | 69.630 | 44.301 | 47.105 | 52.390 |
| Inventories | 21.111 | 1.278 | 31.156 | 14.826 | 20.351 | 4.205 | 21.674 | 702 | 5.101 | 15.396 |
| Receivables | 3.603 | 1.466 | 3.727 | 11.318 | 8.098 | 8.459 | 9.214 | 8.868 | 8.254 | 8.020 |
| Cash | 26.770 | 23.670 | 14.991 | 21.241 | 19.855 | 27.229 | 38.742 | 34.730 | 33.751 | 28.975 |
| Shareholders Funds | 7.263 | 20.623 | 42.059 | 31.682 | 31.673 | 19.126 | 42.822 | 23.118 | 25.833 | 32.504 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 54.420 | 15.369 | 16.547 | 23.892 | 24.058 | 27.978 | 33.541 | 27.078 | 26.903 | 25.746 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Profarm Farmacia Elixir Boldesti S.r.l.